ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.91) by 19.78 percent. This is a 4.29 percent decrease over losses of $(0.70) per share from the same period last year.
US Proposes Tougher AI Guidelines To Prevent Exploitation, Discrimination And Abuse
The White House proposed a non-binding Artificial Intelligence (AI) Bill of Rights likely to help parents, patients and workers avert harm from the increasing use of automation in education, health care, and employment.
